bpc 157 safety humans case report BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase Is BPC‑157 a Risk? Safety,
Description
The main risks stem from its unapproved status and potential for improper compounding
Kidani, Y
(2016) Klicek R, et al
9 Numerous studies published in the last few years provide an update on the efficacy of the two primary treatment options
